ACCESS Newswire

CESI Spa

Share
CESI Solar Cells Fuels the Satellites of the Global Internet

MILAN, ITALY / ACCESSWIRE / April 24, 2024 / The Italian group CESI has secured a contract, with options valued at over one hundred million euros over five years, with one of the world's leading companies in the production of space systems. According to the agreement, CESI is tasked with providing hundreds of thousands of solar cells over these five years, enough to equip eight satellites per month.

To view this piece of content from cdn.nwe.io, please give your consent at the top of this page.
CESI thin space solar cell

These cells will power American space satellites, providing them with the energy needed to bring the internet to every corner of our planet, including the poles. This is a strategically significant investment that places CESI and Italy at the forefront of the Space Economy.

"The recent contract signed is not just a sign of our technological competence but also of our ability to be an integral part of ambitious projects. Space technologies will increasingly support terrestrial applications, thus contributing to the improvement of life on our planet. This implies profound expertise for their development in the years to come. CESI is ready for this challenge," says the CEO of the Group, Domenico Villani.

Within this context, CESI has leveraged proprietary technologies to design, produce, and test solar cells in its Milan laboratories. These cells now power over a hundred civilian satellites for clients across twenty-five countries worldwide. CESI's solar cells are made from materials like gallium arsenide and indium gallium phosphide, exceptionally suited to the harsh conditions of space, where common terrestrial silicon solar cells would not adequately withstand.

The Italian multinational has developed several groundbreaking technologies, including flexible cells that can conform to the surfaces of satellites or spacecraft, and the Integral Assembly. This innovation focuses on optimizing the cell assembly process, eliminating the need for protective glass and thereby reducing the weight and launch costs of satellites. CESI's cells are qualified for both low Earth orbit (LEO) and geostationary orbit (GEO) satellites.

Finally, the company stands as one of only four global manufacturers of these products and the sole proprietor with complete European control.

Space solar cells convert solar energy into electricity in harsh environmental conditions, providing power to satellites. They are light, compact, and highly efficient, crucial features for minimizing launch costs and maximizing satellite payload capacity. Moreover, they withstand extreme temperatures and radiation, ensuring stable and continuous power supply. In short, they are an essential element for the functioning of satellites in orbit, devices for which a significant production increase is expected, given their use on various fronts beyond the traditional telecommunications.

CESI For nearly seventy years, CESI has been offering its clients, spread across more than 70 countries, a range of services in innovation, digitalization, testing, engineering, and consultancy for the electrical sector as well as in civil and environmental engineering. CESI is among the few companies globally that develop and produce advanced solar cells for space applications.

Contact Information

Paolo Chighine
Executive Vice President Group External Relations
paolo.chighine@cesi.it

Davide Cospito
Media Manager Group External Relations
davide.cospito@cesi.it
+39 02 2125 5032

SOURCE: CESI SpA

To view this piece of content from stats.nwe.io, please give your consent at the top of this page.

View the original press release on newswire.com.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

Karbon-X Celebrates Major Milestone in Senegal Mangrove Restoration Project28.10.2025 13:00:00 CET | Press release

Planting completed across 7,000 hectares in partnership with Woodside Energy, advancing community-led climate action. DAKAR, SN / ACCESS Newswire / October 28, 2025 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company") is proud to announce a significant milestone in its ABC Mangrove Project, one of West Africa's largest community-led restoration initiatives with the successful completion of planting across more than 7,000 hectares of mangroves along Senegal's coastline. Developed through ALLCOT, Karbon-X's project development and advisory arm (ALLCOT-A Karbon-X Company), and in partnership with Woodside Energy, the project is helping restore critical blue-carbon ecosystems that protect biodiversity, strengthen local economies, and capture carbon naturally from the atmosphere. Through this multi-year effort, thousands of local community members have been engaged in the planting and care of mangroves, creating new jobs, skills training, and sustainable income opportunities for wome

Florence Healthcare Launches SiteLink on AWS Marketplace, Extending its Clinical Trial Operations Platform Capabilities to Cloud28.10.2025 13:00:00 CET | Press release

ATLANTA, GEORGIA / ACCESS Newswire / October 28, 2025 / Florence Healthcare, the leading clinical trial platform connecting pharmaceutical sponsors and research sites worldwide, announced today that SiteLink, a key offering of Florence's Trial Operations Platform, is now available in AWS Marketplace. SiteLink accelerates study startup and enables real-time document distribution, monitoring, and data exchange with study sites, addressing the critical digital divide in clinical trials. With only 30% of global research sites currently using digital workflows, SiteLink helps bridge this gap by automating sponsor-site operational workflows. Bringing the Florence Trial Operations Platform Benefits to AWS As a core component of Florence's Trial Operations Platform, SiteLink delivers the same proven results that have made Florence the #1 clinical trial management solution for six consecutive years. The platform enables: Faster Startup: Up to 70% faster study activation timelines through automa

GoodData Brings AI-Native Data Intelligence to Financial Services28.10.2025 10:00:00 CET | Press release

Embeddable, compliant, and auditable AI agents unlock trusted automation for banks, insurers, and financial institutions. SAN FRANCISCO, CA / ACCESS Newswire / October 28, 2025 / GoodData, a leading analytics and data intelligence company, today unveiled new finance-focused applications for its composable AI platform, designed to tackle the industry's toughest challenges. By combining its AI Lake, AI Hub, and AI Apps into a single foundation for enterprise data intelligence, the next-generation platform gives financial institutions powerful tools to build and deploy AI agents. These agents can detect and investigate fraud in seconds with audit trails regulators can trust, keeping portfolios compliant in real time within industry guidelines. This streamlines regulatory reporting by compiling, checking, and submitting disclosures transparently, all while meeting strict standards for financial compliance, governance, and security. Purpose-built for finance The financial services sector fa

Cambridge Isotope Laboratories, Inc. Unveils ISOAPI-D - a New Standard in Deuterated Reagents for Pharmaceutical Innovation - at CPhI Frankfurt 202527.10.2025 14:00:00 CET | Press release

With ISOAPI-D, CIL offers pharmaceutical partners a secure, global supply of deuterated reagents - manufactured to the highest quality standards for faster, more efficient API development. TEWKSBURY, MASSACHUSETTS / ACCESS Newswire / October 27, 2025 / Cambridge Isotope Laboratories, Inc. (CIL), a global leader in stable isotope chemistry, announces the launch of ISOAPI-D™, a unified brand of deuterated intermediates for API synthesis. The new ISOAPI-D brand will be launched at CPhI Frankfurt, where CIL welcomes industry professionals to stand #2.0G2 from October 28-30.ISOAPI-D ISOAPI-D Power of Deuterium: Smarter, Stronger Therapeutics "ISOAPI-D reagents are designed to support the development of next-generation active pharmaceutical ingredients (APIs) by leveraging the unique benefits of deuterium incorporation," said Cliff Caldwell, CEO of CIL. "With ISOAPI-D, our customers gain access to a trusted and secure supply chain, ensuring they have consistent, reliable access to the materi

Cambridge Isotope Laboratories, Inc. and Chemtatva Chiral Solutions Pvt. Ltd. to Establish Cambridge Isotope Laboratories, Pvt. Ltd. in Hyderabad, India27.10.2025 13:45:00 CET | Press release

Strategic Partnership to Establish Cambridge Isotope Laboratories, Pvt. Ltd. in Hyderabad's Genome Valley, Enhancing Global Production and Supply of Isotopically Enriched Chemical Solutions for Pharmaceutical and Electronics Industries TEWKSBURY, MA AND HYDERABAD, INDIA / ACCESS Newswire / October 27, 2025 / Cambridge Isotope Laboratories, Inc. (CIL), and Chemtatva Chiral Solutions, Pvt. Ltd. (CCS), a leading provider of chiral and specialty chemical solutions, announce the execution of a signed Memorandum of Understanding to establish Cambridge Isotope Laboratories, Pvt. Ltd. in Hyderabad, India. This initiative marks a milestone in the expansion of CIL's global footprint and further enhances capabilities in the development and production of deuterated reagents and other isotopically enriched products. This partnership will enhance global supply chain strength and real-time support for customers in Asia and enable multi-site production for global customers focused on business continui

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye